イスラエル -
ヘブライ語 -
Ministry of Health
medical access.for respiration,suction,
קובידיאן (ישראל) בע"מ - אחות - אביזרים למערכות הנשמה,שאיבה,והרדמה
イスラエル -
ヘブライ語 -
Ministry of Health
ויטליפיד אן מבוגרים
cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - תרכיז להכנת תמיסה לאינפוזיה - phytomenadione 15 mcg/ml; ergocalciferol 0.5 mcg/ml; tocopherol 0.91 mg/ml; retinol palmitate 194.1 mcg/ml - combinations - combinations - vitalipid n adult is indicated in adult and children above 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.
イスラエル -
ヘブライ語 -
Ministry of Health
ויטאליפיד אן לילדים
cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - תרכיז להכנת תמיסה לאינפוזיה - phytomenadione 20 mcg/ml; ergocalciferol 1 mcg/ml; tocopherol 0.64 mg/ml; retinol palmitate 135.3 mcg/ml - combinations of electrolytes - combinations of electrolytes - vitalipid n infants is indicated in infants and children up to 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.
イスラエル -
ヘブライ語 -
Ministry of Health
פרואבניר
bioavenir ltd, israel - finasteride - טבליות מצופות פילם - finasteride 1 mg - finasteride - finasteride - proavenir is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss.
イスラエル -
ヘブライ語 -
Ministry of Health
מדיטבין 200 מ"ג
medison pharma ltd - gemcitabine as hydrochloride 200 mg/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.
イスラエル -
ヘブライ語 -
Ministry of Health
מדיטבין 200 מ"ג
medison pharma ltd - gemcitabine as hydrochloride 200 mg/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.
イスラエル -
ヘブライ語 -
Ministry of Health
מדיטבין 1 גרם
medison pharma ltd - gemcitabine as hydrochloride 1 g/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.
イスラエル -
ヘブライ語 -
Ministry of Health
מדיטבין 1 גרם
medison pharma ltd - gemcitabine as hydrochloride 1 g/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.